Our Authors
Associate Professor Prue Cormie, Australian Catholic University Associate Professor Prue Cormie is an accredited exercise physiologist whose research and clinical work focuses on the application of exercise as medicine for the management of cancer. She aims to enhance the lives of people with cancer through innovative research and effectively translating research into practice. More information on her work is available here: www.iha.acu.edu.au/cancer.4 Articles
Dr Prunella Blinman is a medical oncologist at the Concord Cancer Centre who specialises in the management of thoracic and gastrointestinal cancers. She is also a clinical senior lecturer at the Sydney Medical School, and an active researcher and supervisor of postgraduate students. She enjoys attending the ASCO Annual Meeting for the educational and networking opportunities.4 Articles
Ian Davis is Professor of Medicine, Monash University and Eastern Health Head, Eastern Health Clinical School and Medical oncologist, Eastern Health Chair. He is also Chair of the ANZUP Cancer Trials Group.4 Articles
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.3 Articles
Dr Hilda High is medical oncologist specialising in cancer genetics. She has worked with familial cancer services at the Prince of Wales Hospital, Westmead Hospital and Royal North Shore Hospitals and now works with Sydney Cancer Genetics through rooms at the SAN, in Ultimo in Sydney and via telehealth to rural and regional Australia.3 Articles
Behavioural scientist with extensive experience in cancer clinical research, in particular post-cancer diagnosis supportive care and psycho-oncology.3 Articles
With a portfolio representing a continuum of activities spanning from prescription drugs and consumer healthcare products to dermo-cosmetics, Pierre Fabre is the second largest dermo-cosmetics laboratory in the world, the second largest private French pharmaceutical group and the market leader in France for products sold over the counter in pharmacies. Its portfolio includes several global brands and franchises, such as Pierre Fabre Oncologie.2 Articles
Associate Professor Mirette Saad is a Consultant Chemical Pathologist and the National Clinical Director of Molecular Genetic Pathology at Australian Clinical Labs. At Clinical Labs, A/Prof Mirette Saad leads the Molecular Genetic testing for Non-Invasive Prenatal Testing (NIPT), carrier screening, personalised drug therapy and cancer. She is a member of the RCPA Chemical Pathology Advisory Committee and a Chair of precision medicine services at Australian Clinical Labs.2 Articles
Prof Bogda Koczwara is a medical oncologist and a senior staff specialist at the Flinders Centre for Innovation in Cancer. Prof Koczwara completed her oncology training at the Roswell Park Cancer Institute in Buffalo, New York and received a Master in Bioethics degree from the Monash University. Her clinical interests revolve around management of breast cancer, cancer survivorship, psycho-oncology and supportive care as well as health services development, integration with primary care and cancer education for health care professionals. Prof Koczwara's interest in needs of cancer survivors have led to her developing a Survivorship Program at Flinders that aims to promote excellence in clinical care and research relating to the needs of cancer survivors. She is the National Breast Cancer Foundation Practitioner Fellow working on the chronic disease management after cancer.2 Articles
Dr Diana Adams is a Consultant Medical Oncologist at Macarthur Cancer Therapy Centre, Sydney South West Area Health Service.2 Articles